CIS
IDXX icon

Capital International Sarl’s Idexx Laboratories IDXX Stock Holding History

Capital International Sarl’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-25,103
Closed -$13.9M – 251
2023
Q4 		$13.9M Buy
25,103
+2,520
+11% +$1.18M 0.52% 59
2023
Q3 		$9.87M Buy
22,583
+1,516
+7% +$756K 0.45% 70
2023
Q2 		$10.6M Buy
21,067
+1,661
+9% +$796K 0.47% 70
2023
Q1 		$9.7M Buy
19,406
+2,688
+16% +$1.29M 0.49% 71
2022
Q4 		$6.82M Buy
16,718
+2,364
+16% +$918K 0.48% 74
2022
Q3 		$4.68M Buy
14,354
+1,451
+11% +$533K 0.38% 85
2022
Q2 		$4.53M Buy
12,903
+1,862
+17% +$759K 0.36% 92
2022
Q1 		$6.04M Sell
11,041
-408
-4% -$215K 0.3% 97
2021
Q4 		$7.54M Buy
11,449
+9,166
+401% +$5.75M 0.36% 85
2021
Q3 		$1.42M Sell
2,283
-168
-7% -$113K 0.13% 152
2021
Q2 		$1.55M Buy
2,451
+388
+19% +$214K 0.13% 154
2021
Q1 		$1.01M Buy
2,063
+182
+10% +$91.2K 0.1% 173
2020
Q4 		$940K Buy
1,881
+159
+9% +$71.1K 0.1% 165
2020
Q3 		$677K Buy
1,722
+20
+1% +$7.39K 0.08% 163
2020
Q2 		$562K Buy
1,702
+502
+42% +$145K 0.07% 168
2020
Q1 		$291K Buy
+1,200
New +$313K 0.05% 168

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Sarl's IDXX Position: Q1 2024 in Review

Capital International Sarl sold out of Idexx Laboratories (IDXX) in Q1 2024, closing a stake of 25,103 shares — an estimated $13.9M sold.

Capital International Sarl first reported a position in IDXX in Q1 2020 and held it in 16 quarters. The position peaked at $13.9M in Q4 2023. 1,149 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.

  • Capital International Sarl reported no remaining Idexx Laboratories position as of Q1 2024 after selling out during the quarter.
  • Capital International Sarl sold 25,103 Idexx Laboratories shares in Q1 2024, an estimated $13.9M.
  • Capital International Sarl first reported a position in Idexx Laboratories in Q1 2020 and held it in 16 quarters.
  • Capital International Sarl's Idexx Laboratories position peaked at $13.9M in Q4 2023.
  • 1,149 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.

Based on Capital International Sarl's 13F filing for Q1 2024, filed 14 May 2024.